Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

K. H. Shain, Terry H Landowski, I. Buyuksal, A. B. Cantor, W. S. Dalton

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

CD95 (Fas/APO-1) is a member of the TNFR superfamily that induces apoptosis following cross-linking with its cognate ligand, CD95L (FasL/APO-1L) or agonist antibody. The human myeloma cell line, RPMI 8226, has limited sensitivity to CD95-mediated apoptosis, with a maximum of 65% of the population responding. To determine the source of the limited sensitivity to CD95-mediated apoptosis, we isolated multiple clones from the RPMI-8226 cell line by limiting dilution. Analysis of these clones demonstrated that sensitivity to CD95-mediated cell death directly correlated with CD95 expression. Clones with high levels of CD95 expression had greater than 90% cell death, whereas cells with low levels of expression had less than 10% cell death. In contrast, no correlative differences were identified for other members of the DISC complex, or for members of the anti-apoptotic Bcl-2 family. We further examined the sensitivity of the 8226 clones to various cytotoxic agents. Although modest clonal variability was demonstrated in response to the chemotherapeutic drugs, doxorubicin, etoposide (VP-16), and vincristine, there was no correlation between CD95 function and sensitivity to chemotherapeutic drugs. These results indicate that in this cell line, receptor expression is rate limiting in CD95-mediated apoptosis, whereas CD95 expression was not a determinant in drug-induced programmed cell death.

Original languageEnglish (US)
Pages (from-to)830-840
Number of pages11
JournalLeukemia
Volume14
Issue number5
StatePublished - 2000
Externally publishedYes

Fingerprint

Multiple Myeloma
Cell Death
Clone Cells
Apoptosis
Drug Therapy
Cell Line
Etoposide
Pharmaceutical Preparations
Fas Ligand Protein
Cytotoxins
Vincristine
Doxorubicin
Ligands
Antibodies
Population

Keywords

  • Apoptosis
  • CD59/Fas/APO-1
  • Chemotherapy
  • Clonal variability
  • Drug resistance
  • Multiple myeloma

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line. / Shain, K. H.; Landowski, Terry H; Buyuksal, I.; Cantor, A. B.; Dalton, W. S.

In: Leukemia, Vol. 14, No. 5, 2000, p. 830-840.

Research output: Contribution to journalArticle

@article{8b21c01b22f145bc9c2a71c82b53207e,
title = "Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line",
abstract = "CD95 (Fas/APO-1) is a member of the TNFR superfamily that induces apoptosis following cross-linking with its cognate ligand, CD95L (FasL/APO-1L) or agonist antibody. The human myeloma cell line, RPMI 8226, has limited sensitivity to CD95-mediated apoptosis, with a maximum of 65{\%} of the population responding. To determine the source of the limited sensitivity to CD95-mediated apoptosis, we isolated multiple clones from the RPMI-8226 cell line by limiting dilution. Analysis of these clones demonstrated that sensitivity to CD95-mediated cell death directly correlated with CD95 expression. Clones with high levels of CD95 expression had greater than 90{\%} cell death, whereas cells with low levels of expression had less than 10{\%} cell death. In contrast, no correlative differences were identified for other members of the DISC complex, or for members of the anti-apoptotic Bcl-2 family. We further examined the sensitivity of the 8226 clones to various cytotoxic agents. Although modest clonal variability was demonstrated in response to the chemotherapeutic drugs, doxorubicin, etoposide (VP-16), and vincristine, there was no correlation between CD95 function and sensitivity to chemotherapeutic drugs. These results indicate that in this cell line, receptor expression is rate limiting in CD95-mediated apoptosis, whereas CD95 expression was not a determinant in drug-induced programmed cell death.",
keywords = "Apoptosis, CD59/Fas/APO-1, Chemotherapy, Clonal variability, Drug resistance, Multiple myeloma",
author = "Shain, {K. H.} and Landowski, {Terry H} and I. Buyuksal and Cantor, {A. B.} and Dalton, {W. S.}",
year = "2000",
language = "English (US)",
volume = "14",
pages = "830--840",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Clonal variability in CD95 expression is the major determinant in Fas-mediated, but not chemotherapy-mediated apoptosis in the RPMI 8226 multiple myeloma cell line

AU - Shain, K. H.

AU - Landowski, Terry H

AU - Buyuksal, I.

AU - Cantor, A. B.

AU - Dalton, W. S.

PY - 2000

Y1 - 2000

N2 - CD95 (Fas/APO-1) is a member of the TNFR superfamily that induces apoptosis following cross-linking with its cognate ligand, CD95L (FasL/APO-1L) or agonist antibody. The human myeloma cell line, RPMI 8226, has limited sensitivity to CD95-mediated apoptosis, with a maximum of 65% of the population responding. To determine the source of the limited sensitivity to CD95-mediated apoptosis, we isolated multiple clones from the RPMI-8226 cell line by limiting dilution. Analysis of these clones demonstrated that sensitivity to CD95-mediated cell death directly correlated with CD95 expression. Clones with high levels of CD95 expression had greater than 90% cell death, whereas cells with low levels of expression had less than 10% cell death. In contrast, no correlative differences were identified for other members of the DISC complex, or for members of the anti-apoptotic Bcl-2 family. We further examined the sensitivity of the 8226 clones to various cytotoxic agents. Although modest clonal variability was demonstrated in response to the chemotherapeutic drugs, doxorubicin, etoposide (VP-16), and vincristine, there was no correlation between CD95 function and sensitivity to chemotherapeutic drugs. These results indicate that in this cell line, receptor expression is rate limiting in CD95-mediated apoptosis, whereas CD95 expression was not a determinant in drug-induced programmed cell death.

AB - CD95 (Fas/APO-1) is a member of the TNFR superfamily that induces apoptosis following cross-linking with its cognate ligand, CD95L (FasL/APO-1L) or agonist antibody. The human myeloma cell line, RPMI 8226, has limited sensitivity to CD95-mediated apoptosis, with a maximum of 65% of the population responding. To determine the source of the limited sensitivity to CD95-mediated apoptosis, we isolated multiple clones from the RPMI-8226 cell line by limiting dilution. Analysis of these clones demonstrated that sensitivity to CD95-mediated cell death directly correlated with CD95 expression. Clones with high levels of CD95 expression had greater than 90% cell death, whereas cells with low levels of expression had less than 10% cell death. In contrast, no correlative differences were identified for other members of the DISC complex, or for members of the anti-apoptotic Bcl-2 family. We further examined the sensitivity of the 8226 clones to various cytotoxic agents. Although modest clonal variability was demonstrated in response to the chemotherapeutic drugs, doxorubicin, etoposide (VP-16), and vincristine, there was no correlation between CD95 function and sensitivity to chemotherapeutic drugs. These results indicate that in this cell line, receptor expression is rate limiting in CD95-mediated apoptosis, whereas CD95 expression was not a determinant in drug-induced programmed cell death.

KW - Apoptosis

KW - CD59/Fas/APO-1

KW - Chemotherapy

KW - Clonal variability

KW - Drug resistance

KW - Multiple myeloma

UR - http://www.scopus.com/inward/record.url?scp=0034105898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034105898&partnerID=8YFLogxK

M3 - Article

C2 - 10803514

AN - SCOPUS:0034105898

VL - 14

SP - 830

EP - 840

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -